AIDX 20/20 Biolabs, Inc.
$0.56▲ +4.85%
Healthcare
Other
After hours
$0.57▲ +1.00%
Sep 11, 7:32 PM ET
Volume 44.6K
Avg Volume (10D) 74.4K
Key Metrics & Fundamentals
Market Cap
$7.15M
P/E Ratio
–
Div Yield
–%
52W Range
0.40 - 50.00
% vs 50 MA
5.42%
% vs 200 MA
–%
RSI-14
49.6
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.39
Free Cash Flow
-$612,960
Gross Rev
$730,571
Gross Profit
$304,727
EBITDA
-$1.22M
COGS
$425,844
Operating Exp
$1.55M
Operating Income
-$1.24M
EBIT
-$1.24M
Pretax Income
-$1.51M
Net Income
-$1.51M
EPS (Diluted)
-0.26
Price & Volume History
Loading chart…
Recent News
20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
GlobeNewswire · Aug 28, 2026 10:26 PM
20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
GlobeNewswire · Aug 26, 2026 12:31 PM
20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level
GlobeNewswire · Aug 17, 2026 12:31 PM
20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management’s Recent East Asia Business Development Tour
GlobeNewswire · Jul 30, 2026 12:31 PM
20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy
GlobeNewswire · Jul 27, 2026 8:30 PM
20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock
GlobeNewswire · Jul 23, 2026 12:31 PM
20/20 BioLabs Highlights Investor Webinar Focused on OneTest™ for Medicare, Serial Biomarker Tracking, and Strong Q2 Revenue Growth
GlobeNewswire · Jul 9, 2026 8:01 PM
20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month
GlobeNewswire · Jun 22, 2026 8:45 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See AIDX's money flow as a full page
Social Sentiment
Avg +0.80 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.